Scholars Central

CommentaryPublished 6 Apr 2017

Specific Peptide Surface Coating: A Hint to Tune the Inflammatory Response of Nano Crystals

Authors: Pengfei W, Mengru L, Yi Hu, Longpingwen

1The CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Signaling Network, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui, China; 2Hefei National Laboratory for Physical Sciences at Microscale, Hefei, Anhui, China; 3Fujian Longsheng Biotechnology Co. Ltd., Longyan, Fujian, China; 4Anhui Provinicial Hospital, Hefei, Anhui, China

Journal of Mucosal Immunology Research

Volume 1 · Issue 1 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We provided a comprehensive line of evidence indicating Lanthanide-based nanoparticles elicited NLRP3 dependent inflammasome activation in vitro and inflammatory response in vivo. A short synthetic peptide identified by our group, RE-1(ACTARSPWICG), could form a stable coating layer on the surface of Lanthanide-based nanoparticles (LNs) through specifically binding and effectively block their autophagy-inducing activity and liver toxicity. Recently, RE-1 coating were also demonstrated to significantly abrogate LN-elicited inflammasome activation without influencing cell uptake of nanocrystals in macrophage cells, and inflammatory response in peritoneal cavity. Furthermore, the mechanism of the inflammasome-inhibiting effect of RE-1 coating was investigated. RE-1 coating did not effectively reduce LN-elicited potassium efflux, while the potassium channel inhibitor glibenclamide did, indicating that potassium efflux was necessary but insufficient for LN-induced inflammasome activation. RE-1 did reduce lysosomal damage induced by LNs, However, the inhibitor of cathepsin B could not alter LN-elicited caspase-1 activation and IL-1β release, indicating that lysosomal damage was not critically important for LN-induced inflammasome activation. In contrast, RE-1 could dramatically inhibit LN-induced up-regulation of intracellular reactive oxygen species (ROS), greatly important for inflammasome activation. And, the reduction on NADPH oxidase-generated ROS was more critical for RE-1's inflammasome-inhibiting effect than the reduction on mitochondria-generated ROS. ROS generation further triggered Transient Receptor Potential M2 (TRPM2) regulated Ca2+ influx to induce inflammasome activation, which could be completely canceled by RE-1 coating. In conclusion, RE-1 primarily inhibited NADPH oxidase regulated ROS generation and subsequently curbed TRPM2-mediated Ca2+ influx to abrogate LN-induced inflammasome activation. Our study gives a new direction to modulate the inflammatory response of nanocrystals to realize immune escape via surface peptide coating, great value for in vivo applications of engineered nanomaterials.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Mucosal Immunology Research
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Pengfei W”
  • BylineArticles whose byline prints “Mengru L”
  • BylineArticles whose byline prints “Yi Hu”
  • BylineArticles whose byline prints “Longpingwen”